Editas Medicine, Inc.
EDIT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$237,093 | -$153,219 | -$220,432 | -$192,502 |
| Dep. & Amort. | $5,809 | $6,064 | $6,337 | $5,053 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $21,417 | $19,798 | $29,294 | $43,399 |
| Change in WC | $3,450 | -$1,594 | $8,176 | -$21,410 |
| Other Non-Cash | -$3,867 | -$3,227 | -$724 | $1,657 |
| Operating Cash Flow | -$210,284 | -$132,178 | -$177,349 | -$163,803 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$8,826 | -$4,719 | -$4,118 | -$7,977 |
| Net Acquisitions | $0 | $0 | $18 | $46,489 |
| Inv. Purchases | -$86,217 | -$258,517 | -$315,186 | -$408,891 |
| Inv. Sales/Matur. | $257,189 | $259,505 | $433,354 | $362,402 |
| Other Inv. Act. | $0 | $0 | $0 | -$46,489 |
| Investing Cash Flow | $162,146 | -$3,731 | $114,068 | -$54,466 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $56,027 | $117,079 | $1,284 | $249,459 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $960 | $0 | $32,647 |
| Financing Cash Flow | $56,027 | $118,039 | $1,284 | $282,106 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $7,889 | -$17,870 | -$61,997 | $63,837 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $127,529 | $145,399 | $207,396 | $143,559 |
| End Cash | $135,418 | $127,529 | $145,399 | $207,396 |
| Free Cash Flow | -$219,110 | -$136,897 | -$181,467 | -$171,780 |